22,264 Shares in Integer Holdings Co. (NYSE:ITGR) Purchased by Edgestream Partners L.P.

Edgestream Partners L.P. purchased a new stake in shares of Integer Holdings Co. (NYSE:ITGR - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 22,264 shares of the medical equipment provider's stock, valued at approximately $2,894,000. Edgestream Partners L.P. owned 0.07% of Integer at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Contravisory Investment Management Inc. grew its stake in Integer by 55.9% during the third quarter. Contravisory Investment Management Inc. now owns 223 shares of the medical equipment provider's stock worth $29,000 after buying an additional 80 shares during the period. Huntington National Bank lifted its stake in shares of Integer by 8,933.3% during the third quarter. Huntington National Bank now owns 271 shares of the medical equipment provider's stock worth $35,000 after purchasing an additional 268 shares in the last quarter. Quest Partners LLC boosted its holdings in Integer by 3,688.9% in the 2nd quarter. Quest Partners LLC now owns 341 shares of the medical equipment provider's stock worth $39,000 after acquiring an additional 332 shares during the period. GAMMA Investing LLC raised its stake in shares of Integer by 60.9% during the second quarter. GAMMA Investing LLC now owns 375 shares of the medical equipment provider's stock valued at $43,000 after purchasing an additional 142 shares during the period. Finally, Innealta Capital LLC acquired a new stake in Integer during the 2nd quarter valued at $110,000. 99.29% of the stock is currently owned by institutional investors and hedge funds.

Integer Stock Performance

ITGR traded down $1.76 during trading hours on Monday, hitting $138.74. The company's stock had a trading volume of 211,300 shares, compared to its average volume of 307,416. The company has a current ratio of 3.28, a quick ratio of 2.09 and a debt-to-equity ratio of 0.67. Integer Holdings Co. has a fifty-two week low of $86.42 and a fifty-two week high of $142.00. The company has a 50-day simple moving average of $131.59 and a 200 day simple moving average of $124.64. The firm has a market capitalization of $4.65 billion, a PE ratio of 42.82, a PEG ratio of 2.01 and a beta of 1.09.

Integer (NYSE:ITGR - Get Free Report) last issued its quarterly earnings data on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share for the quarter, beating analysts' consensus estimates of $1.36 by $0.07. The business had revenue of $431.42 million for the quarter, compared to analysts' expectations of $440.59 million. Integer had a net margin of 6.70% and a return on equity of 11.63%. The company's revenue was up 8.7% on a year-over-year basis. During the same period in the previous year, the business earned $1.27 earnings per share. As a group, sell-side analysts expect that Integer Holdings Co. will post 5.33 EPS for the current year.

Analyst Upgrades and Downgrades

ITGR has been the subject of a number of research analyst reports. Piper Sandler restated an "overweight" rating and issued a $140.00 price target (up previously from $125.00) on shares of Integer in a research note on Friday, October 25th. Truist Financial decreased their price target on shares of Integer from $150.00 to $147.00 and set a "buy" rating for the company in a report on Friday, October 25th. Citigroup raised their target price on shares of Integer from $124.00 to $130.00 and gave the stock a "neutral" rating in a report on Tuesday, October 1st. Bank of America increased their price target on Integer from $135.00 to $145.00 and gave the stock a "buy" rating in a research report on Tuesday, October 1st. Finally, KeyCorp upped their price objective on Integer from $139.00 to $144.00 and gave the stock an "overweight" rating in a research note on Tuesday, October 15th. One equities research analyst has rated the stock with a hold rating and seven have issued a buy rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $139.75.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.